ARCH Venture Fund X, L.P.

Insider Reports History

Entity
Company
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Signature
/s/ ARCH Venture Fund X, L.P., By: ARCH Venture Partners X, L.P., its General Partner, By: ARCH Venture Partners X, LLC, its General Partner, By: Mark McDonnell,: attorney in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ARCH Venture Fund X, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. 10%+ Owner Common Stock 12.4M $68.5M $5.50 Feb 8, 2024 Indirect

Insider Reports Filed by ARCH Venture Fund X, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SANA Sana Biotechnology, Inc. Feb 8, 2024 3 $10M 4 Feb 12, 2024 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner